Navigation Links
Topline in Medical News

Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery

SAN DIEGO, Dec. 17 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) today announced positive topline results from Study 304, a Phase III clinical trial of Acetavance(TM), the company's intravenous formulation of acetaminophen, for the treatment of acute pain following abdo...

Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)

SAN DIEGO, Jan. 11 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) today announced top line results of two of the company's four pivotal, Phase III clinical trials of Acetavance(TM), a formulation of acetaminophen for intravenous use. One of these clinical trials did n...

New Survey Reveals High Expectations for Popular Aesthetic Injections

...n Survey NewsWorthy Analysis. February--March 2009. Data on file, Medicis Pharmaceutical Corporation. 2. Kelton Research. Botulinum Toxin Survey topline Report. February--March 2009. Data on file, Medicis Pharmaceutical Corporation. Important Safety Information Dysport (TM) is an acetylcho...

BioTrends Announces a New Syndicated Report Series, LaunchTrends(TM): Feraheme

...x months post launch. The first wave of the LaunchTrends(TM): Feraheme report series will be fielded in mid-August, measuring uptake at one month. topline findings will be available shortly thereafter and the full report will follow in mid-September. About BioTrends Research Group, Inc. BioTrend...

Hard Economic Times Affect Patients, Dentists - and the Tooth Fairy

... topline Findings from a Survey of More Than 300 Dentists 30,000+ Dentists Conv...e of the largest displays of dental products in North America, here are the topline findings from the survey: Does the Tooth Fairy account for inflation?...

The State of the Tooth: Chicago-Area Residents Talk Dental

... health. As we countdown to CDS's annual Midwinter Meeting, one of the largest displays of dental products in North America, here are some of the topline findings from the survey. On the economy's impact on their personal dental care: One out of five Chicago-metro residents (22 p...

Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness

...3%). The survey was conducted between February 4-8, 2009, during the peanut product recall that began on January 12, 2009. Links to the survey topline data and charts "There's a striking level of awareness of this recall, and many people have taken action. But they're not aware of the range of pr...

Beckman Coulter Announces Third Quarter 2008 Results

...t continued, "I am encouraged by balanced, above-market revenue growth across all major regions outside the U.S. and diagnostics product areas. Robust topline growth allowed us to invest in acquisitions of promising new tests, our molecular diagnostics project and expansion of our emerging markets' sales and...

Derma Sciences Announces Commercial Launch of XTRASORB(TM)

...dvanced wound care products, and then to launch and support them with marketing and our growing sales organization. This is what is going to drive our topline growth and profitability." About Derma Sciences Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key prod...

Even before tomato warning, many Americans lacked confidence in the food safety system

...rking as well as it should," said Robert J. Blendon, professor of Health Policy and Political Analysis at the Harvard School of Public Health. Full topline results and Powerpoint charts are available online. Over a third of Americans (38%) worry about getting ill from the food they eat. Concern was gre...
Topline in Medical Technology

CV Therapeutics Announces Topline MERLIN TIMI-36 Results

- Full study results will be presented at the American College of Cardiology's Scientific Session - PALO ALTO, Calif., March 06, 2007 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. announced today that an analysis of unblinded data from the MERLIN TIMI-36 study of ranolazine shows there was no ad...

CombinatoRx Provides Topline Results from Phase 2 RA Study with CRx-139 and Very Low Dose Prednisolone

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 26, 2007 - CombinatoRx, Incorporated (NASDAQ: CRXX) today announced preliminary results of a phase 2 clinical trial studying CRx-139 (a synergistic combination of 3mg prednisolone and the antidepressant paroxetine) and 3mg prednisolone alone, in patients with ...

deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack

REYKJAVIK, Iceland, May 01, 2007 /PRNewswire-FirstCall/ -- deCODE genetics today announced positive top-line results from its Phase I multiple dose clinical trial of DG051, which the company is developing for the prevention of heart attack. In the study, a randomized, double-blind, multi- dose, as...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... CAMBRIDGE, Mass., Aug. 5 /PRNewswire/ -- Radius Health ("Radius") today announced topline Phase 2 data demonstrating that in women with osteoporosis, BA058 -- the company's novel PTHrP (parathyroid hormone-related protein) analog -- signifi...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

... reduction in steroid dose. We hope to have a full presentation of BLISS-52 results at an appropriate scientific meeting later in 2009." topline BLISS-52 results include: -- Based on an intention-to-treat (ITT) analysis, belimumab met its primary efficacy endpoint of superiority v...

Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C

...were infrequent and all resolved with cessation of treatment." Key topline Findings from ACHIEVE 1 Treatment Group Receiving Albinterferon Alfa...roup assigned to receive 900-mcg albinterferon alfa-2b every two weeks, the topline results demonstrate that albinterferon alfa-2b met its primary efficacy end...

Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)

...els with No Reversal of Analgesia SAN CARLOS, Calif., March 2 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) announced positive topline results today from a Phase 2 double-blind, randomized, placebo-controlled study of NKTR-118 in patients with opioid-induced constipation (OIC). NKTR-...

Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin

...n the discovery, development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive topline results from a Phase 2 clinical trial with the intravenous form of its novel anionic quinolone antibiotic, delafloxacin (RX-3341). The double-blind st...

Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update

...dominal laparoscopic surgery (Study 304). Although this trial is not required as part of the Acetavance NDA, the company continues to expect to report topline results from Study 304 in the fourth quarter of 2008. During the third quarter of 2008, and as previously announced, Cadence also revised the expect...

VIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008

... topline Data from Phase 2 CEA and ACS Clinical Trials to be Released Concurrent with AHA Presentation SAN FRANCISCO, Sept. 15 /PRNewswire...
Topline in Biological Technology

Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C

... Key Findings from ACHIEVE 2/3 The topline ACHIEVE 2/3 results include the following key find...900-mcg albinterferon alfa-2b every two weeks, the topline results demonstrate that albinterferon alfa-2b met...ng to the original dose assignment. The following topline results for the treatment group originally randomi...

Neurocrine Biosciences Reports Third Quarter 2008 Results

...this trial has completed randomization in 155 patients. The Company expects topline results from the first three months of treatment in the first quarter of 20...prolide depot. This trial is being conducted in Central and Eastern Europe. topline data from this 3-month double-blind trial of approximately 180 patients sho...

New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes

...and Action in Diabetes) LEAD(TM) (Liraglutide Effect and Action in Diabetes) 6 is the first trial to be reported from the phase 3b LEAD(TM) program. topline results from the LEAD(TM) 6 study were released by Novo Nordisk in a Stock Exchange Announcement on June 6, 2008. The phase 3a LEAD(TM) program, whi...

MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence

...ance as of September 26, 2008 - topline growth ~ 35% of which >10% - topline growth > 45% of which organic >10% orga...

Neurocrine Biosciences Reports Second Quarter 2008 Results

... topline Trial Study Design Endpoints ...te as of the end of July 2008. The Company expects topline results from the first three months of treatment i... is being conducted in Central and Eastern Europe. topline data from this 3-month double-blind trial of appro...

Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes

... prescribing information for Vidaza. Earlier this month, Pharmion announced topline results from the largest study ever conducted in higher-risk MDS, which dem...ety and efficacy in clinical and non-clinical testing; the possibility that topline results from the clinical trial discussed in this press release will not be...
Other Tags
(Date:10/2/2014)... October 02, 2014 USARAD Holdings ... and telemedicine solutions provider including its SecondOpinions.com® division, ... have joined its Executive Team as President & ... Brent Backhaus, USARAD’s new President and COO, is ... of progressively responsible experience in commercial-, medical- and ...
(Date:10/2/2014)... (PRWEB) October 02, 2014 Robins ... from the Associated Builders and Contractors (ABC) of ... at tonight’s banquet held at Sheraton Birmingham Hotel., ... Massachusetts, Healthcare $10 Million to $25 Million, Obelisk ... Dental Clinic, Federal Government $10 Million to $25 ...
(Date:10/2/2014)... Maureen Salamon HealthDay Reporter ... women with a neurotic personality style and prolonged stress ... new research suggests. Tracking 800 women over nearly ... most anxious, jealous and moody -- which they defined ... the risk of developing Alzheimer,s compared to women scoring ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, 2014 (HealthDay ... reduced by breast-feeding. Nor will delaying the introduction of a ... help prevent celiac disease. Those are the conclusions ... New England Journal of Medicine . The new ... celiac disease if mothers breast-feed their babies and introduce gluten ...
(Date:10/1/2014)... researchers from the University of Adelaide have developed a ... of a good outcome from treatment - from their ... on a range of factors, including clinical symptoms, cognitive ... in the patient,s blood. , Speaking in the lead ... University,s Head of Psychiatry , Professor Bernhard ...
Breaking Medicine News(10 mins):Health News:Teleradiology and Telemedicine Pioneers Brent Backhaus and Lorna Backhaus Join USARAD Holdings, INC. & SecondOpinions.com® 2Health News:Teleradiology and Telemedicine Pioneers Brent Backhaus and Lorna Backhaus Join USARAD Holdings, INC. & SecondOpinions.com® 3Health News:Robins & Morton wins nine awards from Associated Builders and Contractors 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 3Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 3Health News:Predicting the future course of psychotic illness 2
(Date:10/2/2014)... SHELTON, Conn. , Oct. 2, 2014 NXT-ID, ... focused on the growing mobile commerce market, announces the airings ... Money and Mad Money. The national ads resumed ... will air October 2 nd and October 3 rd ... The continuing ads that began airing on CNBC ...
(Date:10/1/2014)... take a healthy salad up a level by growing ... in leafy greens. , "In the long run, one ... the salad or making a pill from the plant ... at Case Western Reserve School of Medicine and leader ... cancer organization is funding the research with a three-year, ...
(Date:9/30/2014)... tourists visit the Mediterranean each year, but its ... on Earth. Almost 1,000 alien species, including fish, ... seas through human activities. In the open-access journal ... team of researchers analyzed data from a new ... show how the introduction of alien species has ...
Breaking Biology News(10 mins):CNBC Commercial Airings for Wocket Smart Wallet October 2nd and 3rd 2CNBC Commercial Airings for Wocket Smart Wallet October 2nd and 3rd 3Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3Biodiversity in the Mediterranean is threatened by alien species 2
Other Contents